Science Translational Medicine, 2025 Single-cell analysis of aplastic anemia reveals a convergence of NK and NK-like CD8
+
T cells with a disease-associated TCR signature Lundgren S., Huuhtanen J., Keränen M. et al. Olink Target 96HematologyPathophysiologyPlasma | | | | |
Experimental Dermatology, 2025 Periostin in Bullous Pemphigoid: A Potential Biomarker of Disease Activity and Severity Ran Y., Peng X., Xia Y. et al. Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologySerum | | | | |
Arthritis & Rheumatology, 2025 Plasma Proteomic Profiles Predict Individual Future Osteoarthritis Risk Kang Z., Zhang J., Liu W. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesPatient StratificationPlasma | | | | |
Journal for ImmunoTherapy of Cancer, 2025 Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer Roudko V., Del Valle D., Radkevich E. et al. Olink Target 96OncologyImmunotherapyPatient StratificationSerum | | | | |
PLOS ONE, 2025 Exploratory study of serum protein biomarkers for sudden cardiac arrest using protein extension assay: A case-control study Shin H., Park J., Cha K. et al. Olink Target 96CVDPatient StratificationSerum | | | | |
OncoImmunology, 2025 Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockade Rocha P., Bach R., Masfarré L. et al. Olink Explore 3072/384OncologyImmunotherapyPatient StratificationSerum | | | | |
Virus Genes, 2025 Plasma proteins and herpes simplex virus infection: a proteome-wide Mendelian randomization study Fu C., Xu W., Xu X. et al. Olink Explore 3072/384Infectious DiseasesPathophysiologyPlasma | | | | |
Nature Genetics, 2025 Whole-genome sequencing analysis identifies rare, large-effect noncoding variants and regulatory regions associated with circulating protein levels Hawkes G., Chundru K., Jackson L. et al. Olink Explore 3072/384Wider Proteomics StudiesPathophysiologyPlasma | | | | |
Nature Communications, 2025 Comparative studies of 2168 plasma proteins measured by two affinity-based platforms in 4000 Chinese adults Wang B., Pozarickij A., Mazidi M. et al. Olink Explore 3072/384Wider Proteomics StudiesCross-platform ValidationPlasma | | | | |
Cell Genomics, 2025 Contribution of germline and somatic mutations to risk of neuromyelitis optica spectrum disorder Yata T., Sato G., Ogawa K. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Annals of Neurology, 2025 Distinct Alterations of Inflammatory Biomarkers in Cluster Headache: A Case Control Study Lund N., Westgate C., Søborg M. et al. Olink Target 48NeurologyPathophysiologyPatient StratificationPlasma | | | | |
Journal of Inflammation Research, 2025 Identification of Cardiometabolic Protein Biomarkers for Acute Myocardial Infarction Using Olink Proteomics Tan X., Wang X., Xu S. et al. Olink Target 96CVDPathophysiologyPatient StratificationPlasma | | | | |
Nature Aging, 2025 Large-scale proteomic analyses of incident Parkinson’s disease reveal new pathophysiological insights and potential biomarkers Gan Y., Ma L., Zhang Y. et al. Olink Explore 3072/384NeurologyPathophysiologyPatient StratificationPlasma | | | | |
Cardiovascular Diabetology, 2025 Phenotype-based clusters, inflammation and cardiometabolic complications in older people before the diagnosis of type 2 diabetes: KORA F4/FF4 cohort study Huemer M., Spagnuolo M., Maalmi H. et al. Olink Target 96Metabolic DiseasesPatient StratificationSerum | | | | |
Nature Medicine, 2025 Integrating the environmental and genetic architectures of aging and mortality Argentieri M., Amin N., Nevado-Holgado A. et al. Olink Explore 3072/384Wider Proteomics StudiesAgingPathophysiologyPlasma | | | | |
Brain, Behavior, and Immunity, 2025 Developmental stage of childhood trauma exposure and markers of inflammation at age 24 Murphy J., Healy C., Mongan D. et al. Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma | | | | |
Clinical Cancer Research, 2025 Clinical and Translational Results from PORTER, a Multi-cohort Phase 1 Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer Galsky M., Autio K., Cabanski C. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPatient StratificationSerum | | | | |
Clinical Proteomics, 2025 Admission glucose, HbA1c levels and inflammatory cytokines in patients with acute ST-elevation myocardial infarction Christa M., Dennis F., Philip R. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
ESMO Open, 2025 First-in-human phase I study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and antitumor activity of PF-07209960 in patients with advanced or metastatic solid tumors Naing A., McKean M., Rosen L. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
Gastric Cancer, 2025 Investigating the role of inflammatory cytokines in mediating the effect of gut microbiota on gastrointestinal cancers: a mendelian randomization study Liu W., Hu X., Choy Y. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |